Biyokimyasal Özellikleri ile L - Karnitin

Abd-Allah, A.R., Helal, G.K., Al-Yahya, A.A.,
Aleisa, A.M., Al-Rejaie, S.S., Al-Bakheet,
S.A., 2009. Pro-inflammatory and oxidative
stress pathways which compromise sperm
motility and survival may be altered by L-carnitine. Oxidative Medicine and Cellular
Longevity 2, 73-81.
Arduini, A., 1992. Carnitine and its acetyl esters as
secondary antioxidants? American Heart
Journal 123, 1726-1727.
Arockia Rani, P.J., Panneerselvam, C., 2001. L-carnitine as a free radical scavenger in aging.
Experimental Gerontology 36, 1713-1726.
Arrigoni-Martelli, E., Caso, V., 2001. Carnitine
protects mitocondria and removes toxic acyls
from xenobiotics. Drugs Under Experimental
and Clinical Research 27(1), 27-49.
Balercia, G., Regoli, F., Armeni, T., Koverech, A.,
Mantero, F., Boscaro, M., 2005. Placebo-controlled double-blind randomized trial on the
use of L-carnitine, L-acetylcarnitine, or
combined L-carnitine and L-acetylcarnitine in
men with idiopathic asthenozoospermia.
Fertility and Sterility 84, 662-671
Banji, M.S., 1984. Nutrition and healt implications of
lysin-carnitine relationship. World Review of
Nutrition and Dietetics 44, 185-211.
Bartelloni, M., Canale, D., Izzo, P.L., Giorgi, P.M.,
Meschini, P., Menchini-Fabris, G.F., 1987. L-Carnitine and acetylcarnitine in human sperm
with normal and reduced motility. Acta
Europaea Fertilitatis 18, 29-31.
Baruksal, G., 2010. L-Karnitinin yaşlı sıçanlarda kalp,
karaciğer, beyin ve plazma yağ aisdi profillerine
ve kalp fonksiyonlarına etkisi. Yüksek Lisans
Tezi, İstanbul Üniversitesi Sağlık Bilimleri
Enstitüsü, İstanbul.
Başpınar, N., Kurtoğlu, F., 2003. Vitaminler. ISBN
975-448-168-7. Selçuk Üniversitesi Veteriner
Fakültesi Yayın Ünitesi, Konya.
Binienda, Z.K., Ali, S.F., 2001. Neuroprotective role
of L-carnitine in the 3-nitropropionic acid
induced neurotoxicity. Toxicology Letters 125,
67-73.
Borum, P.R., 1983. Carnitine. The Annual Review of
Nutrition 3, 233-259.
Bremer, J., 1983. Carnitine-metabolism and functions.
Physiology Review 63, 1420-1480.
Bremer, J., 1990. The role of carnitine in intracelluler
metabolism. Journal of Clinical Chemistry
Clinical Biochemistry 28, 297-301.
Brevetti, G., Diehm, C., Lambert, D., 1999. European
multicenter study on propionyl-L-carnitine in
intermittent claudication. Journal of the
American College of Cardiology 34 (5), 1618-1624.
Brevetti, G., Perna, S., 1992. Metabolic and Clinical
Effects of L-carnitine in Peripheral Vascular
Disease. In: Ferrari, R., DiMauro, S., Sherwood,
G. (Eds.), L-carnitine and Its Role in Medicine:
From Function to Therapy. Academic Press,
London, pp. 359-378.
Brooks, D.E., 1979. Carnitine in the male reproductive
tract and its relation to the motabolism of the
epididymis and spermatozoa. Proceding of
Virginia Biochemistry Symposium pp. 219-235.
Burns, K.A., Casillas, E.R., 1989. The metabolism of
acetylcarnitine and acetate by bovine and
hamster epididymal spermatozoa. Biology of
Reproduction 41, 218-226.
Carter, H.E., Bhattacharya, P.K., Weidman, K.R.,
Fraenkel, G., 1952. Chemical studies on
vitamin BT-isolation and characterization as
carnitine. Archives of Biochemistry and
Biophysics 38, 405-416.
Cerretelli, P., Marconi, C., 1990. L-Carnitine
supplementation in humans. The effects of
physical performance. International Journal of
Sports Medicine 11, 1-14.
Chen, W., Huang, Y.C., Shultz, T.D., Mitchell,
M.E., 1998. Urinary, plasma, and erythrocyte
carnitine concentrations during transition to a
lactoovovegetarian diet with vitamin B-6
depletion and epletion in young adult women.
American Journal of Clinical Nutrition 67, 221-230.
Çitil, M., 2002. Veteriner hekimlikte karnitin. Kafkas
Üniversitesi Veteriner Fakültesi Dergisi 8 (1),
77-82.
Coşkun, Ö., Öter, Ş., Korkmaz, A., Sezen, Ş., Öztaş,
E., Cıncık, M., 2000. Yoğun egzersiz ile iskelet
kasında oluşan glikojen azalması, laktik asit
birikmesi ve morfolojik değişikliklere,
karnitinin etkisi. Türkiye Klinikleri Tıp
Bilimleri Dergisi 20, 325-333.
Costell, M., O’Connor, J.E., Grisolia, S., 1989. Age-dependent decrease of L-carnitine content in
muscle of mice and humans. Biochemical and
Biophysical Research Communication 161 (3),
1135-1143.
Da Torre, S.D., Creer, M.H., Progwizd, S.M., Corr,
P.B., 1991. Amphipathic lipid metabolites and
their relation to arrhythmogenesis in ischemic
heart. Journal of Molecular and Cellular
Cardiology 23 (1), 11-22.
De Vivo, D.C., Tein, I., 1990. Primary and secondary
disorders of carnitine metabolism. International
Pediatry 5, 134-141.
Deniz, G., 1999. Karnitin: Sentez, Metabolizma,
Fonksiyon ve İskemik Kalpte Terapötik Önemi.
Türkiye Klinikleri Tıp Bilimleri 19, 55-62.
Duran, M., Loof, N.E., Dorland, L., 1990. Secondary
carnitine deficiency. Journal of Clinical
Chemistry and Clinical Biochemistry 28, 359-363.
Engel, A.G., Rebouche, C.J., 1983. Carnitine
metabolism and inborne errors. Journal of
Inherited Metabolic Disease 7, 38-43.
Erfle, J.D., Fisher, L.J., Sauer, F.D., 1971. Effect of
infusion of carnitine and glucose on blood
glucose, ketones, and free fatty acides of ketotic
cows. Journal of Dairy Science 54, 673-680.
Evans, A., 2003. Dialysis-related carnitine disorder
and levocarnitine pharmacology. The American
Journal of Kidney Diseases 41 (suppl. 4), S13-S26.
Fabriello, R.G., Calabrese, F., 1988. Prevention of
ischemia induced increase in MDA by acetyl
carnitine. Annals of Neurology 24, 114-118.
Feller, A.G., Rudman, D., 2002. Role of carnitine in
human nutrition. Journal of Nutrition 118, 541-547.
Fujisawa, S., Kobayashi, A., Hironoko, Y., 1992.
Effect of L-carnitine and its acyl derivatives in
the ischemic heart. Japanese Heart Journal 33
(5), 693-705.
Garzya, G., Corallo, D., Fiore, A., 1990. Evaluation
of the effects of L-acetylcarnitine on senile
patients suffering form depression. Drugs Under
Experimental and Clinical Research 16, 101-106.
Gülçin, İ., 2006. Antioxidant and antiradical activities
of L-Carnitine. Life Sciences 78, 803-811.
Hagen, T., Liu, J., Lykkesfeldt, J., 2002. Feeding
acetyl-L-carnitine and lipoic acid to old rats
significiantly improves metabolic function
while decreasing oxidative stress. Proceedings
of the National Academy of Sciences 99 (4),
1870-1875.
Harmeyer, J., Schlumbohm, C., 1997. Die
physiologische Bedeutung von L-Carnitin und
Effekte von Carnitinzulagen bei Haustieren. In:
Proc. Vitamine und Zusatztoffe in der
Ernȁhrung von Mensch und Tier. 6.
Symposium, Jena/Thüringen, pp. 42-46.
Heinonen, O.J., 1996. Carnitine and physical exercise.
Sports Medicine 22, 109-132.
Kalaycıoğlu, L., Serpek, B., Nizamlıoğlu, M.,
Başpınar, N., Tiftik, M.A., 2010. Biyokimya.
4. Baskı. Nobel Yayınevi ISBN: 978-975-591-131-1.
Kayaalp, O.S., 1993. Rasyonel Tedavi Yönünden
Tıbbi Farmakoloji, 6. baskı. Ankara: Feryal
Basımevi 3, pp. 2505-2511.
Kopec, B., Fritz, I.B., 1973. Comparison of properties
of carnitine palmitoyltransferase I with dose of
carnitine palmitoyltransferase II, and prepations
of antibodies to carnitine palmitoyltransferases.
The Journal of Biological Chemistry 248, 4069-4079.
Koudelová, J., Mourek, J., Drahota, Z., Rauchová,
H., 1994. Protective effect of carnitine on
lipoperoxide formation in rat brain.
Physiological Research 43, 387-389.
Kudo, N., Barr, A.J., Barr, R.L., Desai, S.,
Lopaschuk, G.D., 1995. High rates of fatty
acid oxydation during reperfusion of ischemic
hearts are associated with a decrease in
malonyl-CoA levels due to an increase in 5-AMP activated protein kinase inhibition of
acetly-CoA carboxylase. The Journal of
Biological Chemistry 270 (229), 17513-17520.
Li, B.U.K., Lloyd, M.L., Gudjonsson, H., Shug,
A.L., Olsen, W.A., 1992. The effect of enteral
carnitine administration in humans. American
Journal of Clinical Nutrition 55, 838-845.
Lopaschuk, G., 2002. Regulation of carbohydrate
metabolism in ischemia and perfusion.
American Heart Journal 139 (2-3), 115-119.
Malone, J.I., Schocken, D.D., Morrison, A.D.,
Gilbertbarness, E., 1999. Diabetic
cardiomyopathy and carnitine deficiencies.
Journal of Diabetes and Its Complications 13
(2), 86-90.
Mansour, H.H., 2006. Protective role of carnitine ester
against radiation-induced oxidative stres in rats.
Pharmacological Research 54 (3), 165-171.
Marcuus, R., Coulston, A.M., 1990. Water Soluble
Vitamins. In: Gilman, A.G., Rall, T.W., Nies,
S.A., (Eds.). The Pharmacological Basis of
Therapeatics, 8
th
ed., Macmillan press, pp.
1545-1547.
Matalliotakis, I., Koumantaki, Y., Evageliou, A.,
Matalliotakis, G., Goumenou, A.,
Koumantakis, E., 2000. L-carnitine levels in
the seminal plasma of fertile and infertile men:
Correlation with sperm quality. International
Journal of Fertility 45 (3), 236-240.
McGarry, J.D., Sen, A., Esser, V., Woeltje, K.F.,
Weis, B., Foster, D.W., 1991. New insights
into mitochondrial carnitine palmitoyl
transferase enzyme system. Biochimie 73, 77-84.
Meier, P.J., 1987. D-Carnitin, harmlos? In:
Gitzelmann, R., Baerlocher, K., Steinmann, B.,
Biyokimyasal Özellikleri ile L - Karnitin 217
(Hrsg.): Carnitin in der medizin. Schattauer,
Stutgart, New York, pp. 101-104.
Moradi, M., Moradi, A., Alemi, M., Ahmadnia, H.,
Abdi, H., Ahmadi, A., Bazargan-Hejazi, S.,
2010. Safety and efficacy of clomiphene citrate
and L-carnitine in idiopathic male infertility: a
comparative study. Urology Journal 7, 188-193.
Mroczkowska, J.E., Gala, H.J., Nalecz, M.J., Nalecz,
K.A., 1997. Evidence for an asymmetrical
uptake of L-carnitine in the blood–brain barrier
in vitro. Biochemistry and Biophysics Research
Communication 241, 127-131.
Nalecz, K.A., Nalecz, M.J.I., 1996. Carnitine-a known
compound, a novel function in neural cells.
Acta Neurobiologiae Experimentalis 56, 597-609.
Newton, G., Burtle, G.H., 1992. Carnitine in Food
Animal Production. In, Carter, A.L. (Ed).
Current Concepts in Carnitine Research. Boca
Raton, F.L., CRC Press Inc., pp. 59-76.
Pepine, C.J., 1991. The Therapeutic potential of
carnitine in cardiovasculer disorders. Clinical
Therapeutics 13, 2-21.
Pettegrew, J., W, Klunk, W.E., Panchalingham, K.,
Kanfer, J.N., Mcclure, R.J., 1995. Clinical
and neurochemical effects of acetyl-L-carnitine
in Alzheimer’s disease. Neurobiology of Aging
16 (1), 1-4.
Rauchova, H., Dobesova, Z., Drahota, Z., Zicha, J.,
Kunes, J., 1998. The effect of chronic L-carnitine treatment on blood pressure and
plasma lipids in spontaneously hypertensive
rats. European Journal of Pharmacology 342,
235-239.
Rebouche, C.J., 1987. Carnitine metabolism and
human nutrition. The Journal of Applied
Nutrition 117, 1024-1031.
Rebouche, C.J., 1999. Carnitine. In: Shils M.E., Olson
J.A., Shike M., Ross A.C., (Eds.) Nutrition in
Health and Disease. 9th ed. Baltimore: Williams
and Wilkins, pp. 505-512.
Rebouche, C.J., Engel, A.G., 1980. Tissue distribution
of carnitine biosynthetic enzymes in man.
Biochimica et Biophysica Acta 630, 22-29.
Rebouche, C.J., Paulson, D.J., 1986. Carnitine
metabolism and function in humans. The
Annual Review of Nutrition 6, 41-66.
Rodrigues, B., Xiang, H., McNeill, J.H., 1988. Effect
of L-Carnitine treatment on lipid metabolism
and cardiac performance in chronically diabetic
rats. Diabetes 37, 1358-1364.
Sahlin, K., 1990. Muscle carnitine metabolism during
incremental dynamic exercise in humans. Acta
Physiologic Scandinavica 138, 259-262.
Schnackenberg, C.G., Wilcox, C., 2001. The SOD
mimetic tempol restores vasodilation in affernt
arterioles of experimental diabetes. Kidney
International 59, 1859-1864.
Scholte, H.R., Jonge, P.C., 1987. Metabolism,
Function and Transport Carnitine in Health and
Disease. In: Gitzelmann, R., Baerlocher, K.,
Steinman, B., (Hrsg.). Carnitin in der medizin,
Schattauer, Stutgart, New York, pp. 21-59.
Scholte, H.R., Pereira, R.R., De Jang, P.C., Luyt
Houwen, I.E.M., Verduin, M.H.M., Ross,
J.D., 1990. Primary carnitine deficiency.
Journal of Clinical Chemistry and Clinical
Biochemistry 28, 351-357.
Shug, A.L., Schmidt, M.J., Golden, G.T., Fariello,
R.T., 1982. The distribution and role of
carnitine in the mammalian brain. Life Sciences
31, 2869-2874.
Şıktar, E., 2008. Hipertermik ve hipotermik su
sıcaklıklarında yorucu yüzme egzersizi
yaptırılan ratlarda L-karnitinin ve termal stresin
serbest radikal ve antioksidan düzeylere etkisi.
Doktora Tezi, Gazi Üniversitesi Sağlık
Bilimleri Enstitüsü, Ankara.
Siliprandi, N., 1982. Carnitine as a Drug Affecting
Lipid Metabolism: General Consideration. In:
Paoletti, R., (Ed.), Hypolipidemic drugs;
Therapeutic Selectivity and Risk/Benefit
Assessment. Raven Press, New York, pp. 265-268.
Treem, W.R., Stanley, C.A., Finegold, D.N., Hale,
D.E., Coates, P.M., 1998. Primary carnitine
deficiency due to a failure of carnitine transport
in kidney, muscle, and fibroblast. The New
England Journal of Medicine 319, 1331-1336.
Vacha, G.M., Giorcelli, G., Siliprandi, N., Corsi, M.,
1983. Favorable effects of L-carnitine treatment
on hypertriglyceridemia in hemodialysis
patients: decisive role of low levels of high-density lipoproteincholesterol. The American
Journal of Clinical Nutrition 38, 532-540.
Vesela, E., Racek, J., Trefil, L., Jankovych, V.,
Pojer, M., 2001. Effect of L-carnitine
218 Halil Yavuz, Firuze Kurtoğlu
supplementation in hemodialysis patients.
Nephron 88 (3), 218-223.
Visioli, O., Pasini, E., de Giuli, F., Ferrari, R., 1992.
Molecular Mechanism of Action of L-carnitine
in Treatment of Myocardial Disorders at the
Experimental Levels. In: Ferrari, R., DiMauro,
S., Sherwood, G., (Eds.), L-carnitine and Its
Role in Medicine: From Function to Therapy.
Academic Press, London, pp. 237-263.
Wächter, S., Vogt, M., Kreis, R., Boesch, C., Bigler,
P., Hoppeler, H., Krähenbühl, S., 2002. Long-term administration of L-carnitine to humans:
Effect on skeletal muscle carnitine content and
physical performance. Clinica Chimica Acta
318 (1-2), 51-61.
Zelnik, N., Fridkis, S., Gruener, N., 1995. Reduced
carnitine and antiepileptic drugs cause
relationship or co-existance. Acta Pediatrica 84,
93-95.